Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial…
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection…
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of…
Vocodia Holdings (VHAI) to Transform Auto Dealership Experience with Groundbreaking AI…
Black Diamond Therapeutics Inc (NASDAQ:BDTX) Surges on Market Optimism
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Cassava Sciences Inc
Tag: Cassava Sciences Inc
Cassava Sciences Inc. (NASDAQ:SAVA) Released Addition Phase 2b Clinical Study Results...
Ward Sport
-
November 10, 2020
0
CTAD 2020 Picks Cassava Sciences Inc.’s (NASDAQ:SAVA) Phase 2b Sumifilam Study...
Matt Wade
-
October 14, 2020
0
Cassava Sciences Inc. (NASDAQ:SAVA) Demonstrates Directional Improvement In Alzheimer’s Patients Treated...
Matt Wade
-
September 17, 2020
0
The USAN Announces a Commercial Brand Name for PTI-125; Lead Drug...
Kate Hudson
-
September 1, 2020
0
Cassava Sciences Inc (NASDAQ:SAVA) Expects To Release Clinical Results Of Phase...
Kate Hudson
-
August 26, 2020
0
Recent Post
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...
Kate Hudson
-
March 26, 2024
0
In a landmark development, the U.S. Food and Drug Administration recently endorsed a groundbreaking therapy by Merck, setting a new course for...
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...
March 25, 2024
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of...
March 25, 2024
Vocodia Holdings (VHAI) to Transform Auto Dealership Experience with Groundbreaking AI...
March 25, 2024
Black Diamond Therapeutics Inc (NASDAQ:BDTX) Surges on Market Optimism
March 22, 2024